Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd Hong Kong S.E.
Equities
3347
CNE1000040M1
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.9 HKD | +2.81% | +0.30% | -6.93% |
25/04 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
25/04 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
ETFs positioned on Hangzhou Tigermed Consulting Co., Ltd
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.29% | 4 M€ | -27.92% | ||
0.59% | 2 M€ | -18.79% | - | |
0.07% | 2 M€ | -.--% | ||
0.03% | 7 M€ | -.--% | - | |
0.03% | 35 M€ | -5.85% | - | |
0.02% | 112 M€ | +4.61% | - | |
0.01% | 2,867 M€ | +5.89% | - | |
0.01% | 454 M€ | +4.02% | - | |
0.01% | 153 M€ | +3.74% | - | |
0.01% | 32 M€ | +6.87% | - | |
0.00% | 7 M€ | +5.36% | - | |
0.00% | 391 M€ | +7.63% | - | |
0.00% | 105 M€ | +2.97% | - | |
0.00% | 34 M€ | +3.86% | - | |
0.00% | 15 M€ | +13.60% | ||
0.00% | 54 M€ | +0.47% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- 300347 Stock
- 3347 Stock
- Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd